AID in antibody perfection

Cellular and Molecular Life Sciences

Volumn 64, Issue 5, 2007, Pages 555-565

  Vallur, A C ^a   Yabuki, M ^a   Larson, E D ^a   Maizels, N ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Activation induced deaminase; Class switch recombination; Gene conversion; Immunoglobulin; Somatic hypermutation

Indexed keywords

ANTIBODY; DEAMINASE; SINGLE STRANDED DNA; DNA; IMMUNOGLOBULIN;

CHROMATIN STRUCTURE; DEAMINATION; DNA REPAIR; DNA STRAND; DNA TEMPLATE; GENE; GENE REPLICATION; GENE TRANSLOCATION; GENETIC VARIABILITY; HUMAN; IMMUNOGLOBULIN GENE; LIFE CYCLE; MUTAGENESIS; NONHUMAN; ONCOGENE; RESEARCH; REVIEW; ARTICLE; DNA REPLICATION; ENZYME ACTIVATION; GENETICS; IMMUNOLOGY; NUCLEOTIDE SEQUENCE; SITE DIRECTED MUTAGENESIS; SOMATIC HYPERMUTATION;

ANTIBODIES; CONSERVED SEQUENCE; DNA; DNA REPLICATION; ENZYME ACTIVATION; GENES, IMMUNOGLOBULIN; HUMANS; IMMUNOGLOBULINS; MUTAGENESIS; MUTAGENESIS, SITE-DIRECTED; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN; TEMPLATES, GENETIC; VARIATION (GENETICS);

EID: 34247895647     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-007-6434-2     Document Type: Review

References (109)

1. Maizels N. (2005) Immunoglobulin gene diversification. Annu. Rev. Genet. 39, 23-46.
2. Arakawa H., Hauschild J. and Buerstedde J.M. (2002) Requirement of the activation-induced deaminase (AID) gene for immunoglobulin gene conversion. Science 295, 1301-1306.
3. Harris R.S., Sale J.E., Petersen-Mahrt S.K. and Neuberger M.S. (2002) AID is essential for immunoglobulin V gene conversion in a cultured B cell line. Curr. Biol. 12, 435-438.
4. Muramatsu M., Kinoshita K., Fagarasan S., Yamada S., Shinkai Y. and Honjo T. (2000) Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102, 553-563.
5. Revy P., Muto T., Levy Y., Geissmann F., Plebani A., Sanal O., Catalan N., Forveille M., Dufourcq-Labelouse R., Gennery A., Tezcan I., Ersoy F., Kayserili H., Ugazio A.G., Brousse N., Muramatsu M., Notarangelo L.D., Kinoshita K., Honjo T., Fischer A. and Durandy A. (2000) Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the hyper-IgM syndrome (HIGM2). Cell 102, 565-575.
6. Muramatsu M., Sankaranand V.S., Anant S., Sugai M., Kinoshita K., Davidson N.O. and Honjo T. (1999) Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J. Biol. Chem. 274, 18470-18476.
7. Maizels N. (1995) Somatic hypermutation: how many mechanisms diversify V region sequences? Cell 83, 9-12.
8. Sale J.E., Calandrini D.M., Takata M., Takeda S. and Neuberger M.S. (2001) Ablation of XRCC2/3 transforms immunoglobulin V gene conversion into somatic hypermutation. Nature 412, 921-926.
9. Scott J. (1995) A place in the world for RNA editing. Cell 81, 833-836.
10. Honjo T., Nagaoka H., Shinkura R. and Muramatsu M. (2005) AID to overcome the limitations of genomic information. Nat. Immunol. 6, 655-661.
11. Petersen-Mahrt S.K., Harris R.S. and Neuberger M.S. (2002) AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature 418, 99-104.
12. Di Noia J. and Neuberger M.S. (2002) Altering the pathway of immunoglobulin hypermutation by inhibiting uracil-DNA glycosylase. Nature 419, 43-48.
13. Rada C., Williams G.T., Nilsen H., Barnes D.E., Lindahl T. and Neuberger M.S. (2002) Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNG-deficient mice. Curr. Biol.12, 1748-1755.
14. Imai K., Slupphaug G., Lee W.I., Revy P., Nonoyama S., Catalan N., Yel L., Forveille M., Kavli B., Krokan H.E., Ochs H.D., Fischer A. and Durandy A. (2003) Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination. Nat. Immunol. 4, 1023-1028.
15. Hagen L., Pena-Diaz J., Kavli B., Otterlei M., Slupphaug G. and Krokan H.E. (2006) Genomic uracil and human disease. Exp. Cell. Res. 312, 2666-2672.
16. Barreto V.M., Pan-Hammarstrom Q., Zhao Y., Hammarstrom L., Misulovin Z. and Nussenzweig M.C. (2005) AID from bony fish catalyzes class switch recombination. J. Exp. Med. 202, 733-738.
17. Conticello S.G., Thomas C.J., Petersen-Mahrt S.K. and Neuberger M.S. (2005) Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases. Mol. Biol. Evol. 22, 367-377.
18. Xie K., Sowden M.P., Dance G.S., Torelli A.T., Smith H.C. and Wedekind J.E. (2004) The structure of a yeast RNA-editing deaminase provides insight into the fold and function of activation-induced deaminase and APOBEC-1. Proc.Natl. Acad. Sci. USA 101, 8114-8119.
19. Ta V.T., Nagaoka H., Catalan N., Durandy A., Fischer A., Imai K., Nonoyama S., Tashiro J., Ikegawa M., Ito S., Kinoshita K., Muramatsu M. and Honjo T. (2003) AID mutant analyses indicate requirement for class-switch-specific cofactors. Nat. Immunol. 4, 843-848.
20. Barreto V., Reina-San-Martin B., Ramiro A.R., McBride K.M. and Nussenzweig M.C. (2003) C-terminal deletion of AID uncouples class switch recombination from somatic hypermutation and gene conversion. Mol. Cell 12, 501-508.
21. Imai K., Zhu Y., Revy P., Morio T., Mizutani S., Fischer A., Nonoyama S. and Durandy A. (2005) Analysis of class switch recombination and somatic hypermutation in patients affected with autosomal dominant hyper-IgM syndrome type 2. Clin. Immunol. 115, 277-285.
22. Shinkura R., Ito S., Begum N.A., Nagaoka H., Muramatsu M., Kinoshita K., Sakakibara Y., Hijikata H. and Honjo T. (2004) Separate domains of AID are required for somatic hypermutation and class-switch recombination. Nat. Immunol. 5, 707-712.
23. Wu X., Geraldes P., Platt J.L. and Cascalho M. (2005) The double-edged sword of activation-induced cytidine deaminase. J. Immunol. 174, 934-941.
24. Manis J.P., Tian M. and Alt F.W. (2002) Mechanism and control of class-switch recombination. Trends Immunol. 23, 31-39.
25. Navaratnam N., Fujino T., Bayliss J., Jarmuz A., How A., Richardson N., Somasekaram A., Bhattacharya S., Carter C. and Scott J. (1998) Escherichia coli cytidine deaminase provides a molecular model for ApoB RNA editing and a mechanism for RNA substrate recognition. J. Mol. Biol. 275, 695-714.
26. Dickerson S.K., Market E., Besmer E. and Papavasiliou F.N. (2003) AID mediates hypermutation by deaminating single stranded DNA. J. Exp. Med. 197, 1291-1296.
27. Wang J., Shinkura R., Muramatsu M., Nagaoka H., Kinoshita K. and Honjo T. (2006) Identification of a specific domain required for dimerization of activation-induced cytidine deaminase. J. Biol. Chem. 281, 19115-19123.
28. Bransteitter R., Sneeden J.L., Allen S., Pham P. and Goodman M.F. (2006) First AID (activation-induced cytidine deaminase) is needed to produce high affinity isotype-switched antibodies. J. Biol. Chem. 281, 16833-16836.
29. Rogozin I.B. and Kolchanov N.A. (1992) Somatic hypermutagenesis in immunoglobulin genes. II. Influence of neighbouring base sequences on mutagenesis. Biochim. Biophys. Acta 1171, 11-18.
30. Rogozin I.B., Solovyov V.V. and Kolchanov N.A. (1991) Somatic hypermutagenesis in immunoglobulin genes. I. Correlation between somatic mutations and repeats. Somatic mutation properties and clonal selection. Biochim. Biophys. Acta 1089, 175-182.
31. Rogozin I.B., Sredneva N.E. and Kolchanov N.A. (1996) Somatic hypermutagenesis in immunoglobulin genes. III. Somatic mutations in the chicken light chain locus. Biochim. Biophys. Acta 1306, 171-178.
32. Jolly C.J., Wagner S.D., Rada C., Klix N., Milstein C. and Neuberger M.S. (1996) The targeting of somatic hypermutation. Semin. Immunol. 8, 159-168.
33. Neuberger M.S., Ehrenstein M.R., Klix N., Jolly C.J., Yelamos J., Rada C. and Milstein C. (1998) Monitoring and interpreting the intrinsic features of somatic hypermutation. Immunol. Rev. 162, 107-116.
34. Bransteitter R., Pham P., Calabrese P. and Goodman M.F. (2004) Biochemical analysis of hypermutational targeting by wild type and mutant activation-induced cytidine deaminase. J. Biol. Chem. 279, 51612-51621.
35. Pham P., Bransteitter R., Petruska J. and Goodman M.F. (2003) Processive AID-catalysed cytosine deamination on single-stranded DNA simulates somatic hypermutation. Nature 424, 103-107.
36. Xue K., Rada C. and Neuberger M.S. (2006) The in vivo pattern of AID targeting to immunoglobulin switch regions deduced from mutation spectra in msh2-/- ung-/- mice. J. Exp. Med. 203, 2085-2094.
37. Fukita Y., Jacobs H. and Rajewsky K. (1998) Somatic hypermutation in the heavy chain locus correlates with transcription. Immunity 9, 105-114.
38. Peters A. and Storb U. (1996) Somatic hypermutation of immunoglobulin genes is linked to transcription initiation. Immunity 4, 57-65.
39. Snapper C.M., Marcu K.B. and Zelazowski P. (1997) The immunoglobulin class switch: beyond "accessibility". Immunity 6, 217-223.
40. Bransteitter R., Pham P., Scharff M.D. and Goodman M.F. (2003) Activation-induced cytidine deaminase deaminates deoxycytidine on single-stranded DNA but requires the action of RNase. Proc. Natl. Acad. Sci. USA 100, 4102-4107.
41. Chaudhuri J., Tian M., Khuong C., Chua K., Pinaud E. and Alt F.W. (2003) Transcription-targeted DNA deamination by the AID antibody diversification enzyme. Nature 422, 726-730.
42. Ramiro A.R., Stavropoulos P., Jankovic M. and Nussenzweig M.C. (2003) Transcription enhances AID-mediated cytidine deamination by exposing single-stranded DNA on the non-template strand. Nat. Immunol. 4, 452-456.
43. Sohail A., Klapacz J., Samaranayake M., Ullah A. and Bhagwat A.S. (2003) Human activation-induced cytidine deaminase causes transcription-dependent, strand-biased C to U deaminations. Nucleic Acids Res. 31, 2990-2994.
44. Nambu Y., Sugai M., Gonda H., Lee C.G., Katakai T., Agata Y., Yokota Y. and Shimizu A. (2003) Transcription-coupled events associating with immunoglobulin switch region chromatin. Science 302, 2137-2140.
45. Milstein C., Neuberger M.S. and Staden R. (1998) Both DNA strands of antibody genes are hypermutation targets. Proc. Natl. Acad. Sci. USA 95, 8791-8794.
46. Rooney S., Chaudhuri J. and Alt F.W. (2004) The role of the non-homologous end-joining pathway in lymphocyte development. Immunol. Rev. 200, 115-131.
47. Shen H.M. and Storb U. (2004) Activation-induced cytidine deaminase (AID) can target both DNA strands when the DNA is supercoiled. Proc. Natl. Acad. Sci. USA 101, 12997-13002.
48. Yu K., Huang F.T. and Lieber M.R. (2004) DNA substrate length and surrounding sequence affect the activation-induced deaminase activity at cytidine. J. Biol. Chem. 279, 6496-6500.
49. Chaudhuri J., Khuong C. and Alt F.W. (2004) Replication protein A interacts with AID to promote deamination of somatic hypermutation targets. Nature 430, 992-998.
50. Muto T., Muramatsu M., Taniwaki M., Kinoshita K. and Honjo T. (2000) Isolation, tissue distribution, and chromosomal localization of the human activation-induced cytidine deaminase (AID) gene. Genomics 68, 85-88.
51. Wolniak K.L., Shinall S.M. and Waldschmidt T.J. (2004) The germinal center response. Crit. Rev. Immunol. 24, 39-65.
52. Rada C., Jarvis J.M. and Milstein C. (2002) AID-GFP chimeric protein increases hypermutation of Ig genes with no evidence of nuclear localization. Proc. Natl. Acad. Sci. USA 99, 7003-7008.
53. McBride K.M., Barreto V., Ramiro A.R., Stavropoulos P. and Nussenzweig M.C. (2004) Somatic hypermutation is limited by CRM1-dependent nuclear export of activation-induced deaminase. J. Exp. Med. 199, 1235-1244.
54. Basu U, Chaudhuri J, Alpert C, Dutt S, Ranganath S, Li G, Schrum J.P., Manis J.P. and Alt F.W. (2005) The AID antibody diversification enzyme is regulated by protein kinase A phosphorylation. Nature 438, 508-511.
55. Pasqualucci L., Kitaura Y., Gu H. and Dalla-Favera R. (2006) PKA-mediated phosphorylation regulates the function of activation-induced deaminase (AID) in B cells. Proc. Natl. Acad. Sci. USA 103, 395-400.
56. McBride KM., Gazumyan A., Woo E.M., Barreto V.M., Robbiani D.F., Chait B.T. and Nussenzweig M.C. (2006) Regulation of hypermutation by activation-induced cytidine deaminase phosphorylation. Proc. Natl. Acad. Sci. USA 103, 8798-8803.
57. Rada C., Di Noia J.M. and Neuberger M.S. (2004) Mismatch recognition and uracil excision provide complementary paths to both Ig switching and the A/T-focused phase of somatic mutation. Mol. Cell 16, 163-171.
58. Neuberger M.S., Di Noia J.M., Beale R.C., Williams G.T., Yang Z. and Rada C. (2005) Somatic hypermutation at A.T pairs: polymerase error versus dUTP incorporation. Nat. Rev. Immunol. 5, 171-178.
59. Di Noia J.M. and Neuberger M.S. (2004) Immunoglobulin gene conversion in chicken DT40 cells largely proceeds through an abasic site intermediate generated by excision of the uracil produced by AID-mediated deoxycytidine deamination. Eur. J. Immunol. 34, 504-508.
60. Saribasak H., Saribasak N.N., Ipek F.M., Ellwart J.W., Arakawa H. and Buerstedde J.M. (2006) Uracil DNA glycosylase disruption blocks Ig gene conversion and induces transition mutations. J. Immunol. 176, 365-371.
61. Di Noia J.M., Rada C. and Neuberger M.S. (2006) SMUG1 is able to excise uracil from immunoglobulin genes: insight into mutation versus repair. EMBO J. 25, 585-595.
62. Larson E.D., Cummings W.J., Bednarski D.W. and Maizels N. (2005) MRE11/RAD50 cleaves DNA in the AID/UNG-dependent pathway of immunoglobulin gene diversification. Mol. Cell 20, 367-375.
63. Yabuki M., Fujii M.M. and Maizels N. (2005) The MRE11-RAD50-NBS1 complex accelerates somatic hypermutation and gene conversion of immunoglobulin variable regions. Nat. Immunol. 6, 730-736.
64. Jansen J.G., Langerak P., Tsaalbi-Shtylik A., Van den Berk P., Jacobs H. and de Wind N. (2006) Strand-biased defect in C/G transversions in hypermutating immunoglobulin genes in Rev1-deficient mice. J. Exp. Med. 203, 319-323.
65. Ross A.L. and Sale J.E. (2006) The catalytic activity of REV1 is employed during immunoglobulin gene diversification in DT40. Mol. Immunol. 43, 1587-1594.
66. Masuda K., Ouchida R., Hikida M., Nakayama M., Ohara O., Kurosaki T. and O-Wang J. (2006) Absence of DNA polymerase theta results in decreased somatic hypermutation frequency and altered mutation patterns in Ig genes. DNA Repair (Amst). 5, 1384-1391.
67. Zan H., Shima N., Xu Z., Al-Qahtani A., Evinger Iii A.J., Zhong Y., Schimenti J.C. and Casali P. (2005) The translesion DNA polymerase theta plays a dominant role in immunoglobulin gene somatic hypermutation. EMBO J. 24, 3757-3769.
68. Larson E.D., Duquette M.L., Cummings W.J., Streiff R.J. and Maizels N. (2005) MutSalpha binds to and promotes synapsis of transcriptionally activated immunoglobulin switch regions. Curr. Biol. 15, 470-474.
69. Wilson T.M., Vaisman A., Martomo S.A., Sullivan P., Lan L., Hanaoka F., Yasui A., Woodgate R. and Gearhart P.J. (2005) MSH2-MSH6 stimulates DNA polymerase eta, suggesting a role for A:T mutations in antibody genes. J. Exp. Med. 201, 637-645.
70. Bardwell P.D., Woo CJ., Wei K., Li Z., Martin A., Sack SZ., Parris C., Edelmann W. and Scharff MD. (2004) Altered somatic hypermutation and reduced class-switch recombination in exonuclease 1-mutant mice.Nat. Immunol. 5, 224-229.
71. Ehrenstein M.R. and Neuberger M.S. (1999) Deficiency in Msh2 affects the efficiency and local sequence specificity of immunoglobulin class-switch recombination: parallels with somatic hypermutation. EMBO J. 18, 3484-3490.
72. Li Z., Peled J.U., Zhao C., Svetlanov A., Ronai D., Cohen P.E. and Scharff M.D. (2006) A role for Mlh3 in somatic hypermutation. DNA Repair (Amst.) 5, 675-682.
73. Li Z., Scherer S.J., Ronai D., Iglesias-Ussel M.D., Peled J.U., Bardwell P.D., Zhuang M., Lee K., Martin A., Edelmann W. and Scharff M.D. (2004) Examination of Msh6- and Msh3-deficient mice in class switching reveals overlapping and distinct roles of MutS homologues in antibody diversification. J. Exp. Med. 200, 47-59.
74. Li Z., Zhao C., Iglesias-Ussel M.D., Polonskaya Z., Zhuang M., Yang G., Luo Z., Edelmann W. and Scharff M.D. (2006) Themismatch repair protein Msh6 influences the in vivo AID targeting to the Ig locus. Immunity 24, 393-403.
75. Martomo S.A., Yang W.W. and Gearhart P.J. (2004) A role for Msh6 but not Msh3 in somatic hypermutation and class switch recombination. J. Exp. Med. 200, 61-68.
76. Phung Q.H., Winter D.B., Cranston A., Tarone R.E., Bohr V.A., Fishel R. and Gearhart P.J. (1998) Increased hypermutation at G and C nucleotides in immunoglobulin variable genes from mice deficient in the MSH2 mismatch repair protein. J. Exp. Med. 187, 1745-1751.
77. Rada C., Ehrenstein M.R., Neuberger M.S. and Milstein C. (1998) Hot spot focusing of somatic hypermutation in MSH2-deficient mice suggests two stages of mutational targeting. Immunity 9, 135-141.
78. Wiesendanger M., Kneitz B., Edelmann W. and Scharff M.D. (2000) Somatic hypermutation in MutS homologue (MSH)3-, MSH6-, and MSH3/MSH6-deficient mice reveals a role for the MSH2-MSH6 heterodimer in modulating the base substitution pattern. J. Exp. Med. 191, 579-584.
79. Wu X., Tsai C.Y., Patam M.B., Zan H., Chen J.P., Lipkin S.M. and Casali P. (2006) A role for the MutL mismatch repair Mlh3 protein in immunoglobulin class switch DNA recombination and somatic hypermutation. J. Immunol. 176, 5426-5437.
80. Delbos F., De Smet A., Faili A., Aoufouchi S., Weill J.C. and Reynaud C.A. (2005) Contribution of DNA polymerase eta to immunoglobulin gene hypermutation in the mouse. J. Exp. Med. 201, 1191-1196.
81. Martomo S.A., Yang W.W., Wersto R.P., Ohkumo T., Kondo Y., Yokoi M., Masutani C., Hanaoka F. and Gearhart P.J. (2005) Different mutation signatures in DNA polymerase eta- and MSH6-deficient mice suggest separate roles in antibody diversification. Proc. Natl. Acad. Sci. USA 102, 8656-8661.
82. Matsuda T., Bebenek K., Masutani C., Rogozin I.B., Hanaoka F. and Kunkel T.A. (2001) Error rate and specificity of human and murine DNA polymerase eta. J. Mol. Biol. 312, 335-346.
83. Zeng X., Winter D.B., Kasmer C., Kraemer K.H., Lehmann A.R. and Gearhart P.J. (2001) DNA polymerase eta is an A-T mutator in somatic hypermutation of immunoglobulin variable genes. Nat. Immunol. 2, 537-541.
84. Kawamoto T., Araki K., Sonoda E., Yamashita Y.M., Harada K., Kikuchi K., Masutani C., Hanaoka F., Nozaki K., Hashimoto N. and Takeda S. (2005) Dual roles for DNA polymerase eta in homologous DNA recombination and translesion DNA synthesis. Mol. Cell 20, 793-799.
85. McIlwraith M.J., Vaisman A., Liu Y., Fanning E., Woodgate R. and West S.C. (2005) Human DNA polymerase eta promotes DNA synthesis from strand invasion intermediates of homologous recombination. Mol. Cell 20, 783-792.
86. Barnes D.E. and Lindahl T. (2004) Repair and genetic consequences of endogenous DNA base damage in mammalian cells. Annu. Rev. Genet. 38, 445-476.
87. Okazaki I.M., Kinoshita K., Muramatsu M., Yoshikawa K. and Honjo T. (2002) The AID enzyme induces class switch recombination in fibroblasts. Nature 416, 340-345.
88. Yoshikawa K., Okazaki I.M., Eto T., Kinoshita K., Muramatsu M., Nagaoka H. and Honjo T. (2002) AID enzyme-induced hypermutation in an actively transcribed gene in fibroblasts. Science 296, 2033-2036.
89. Longerich S., Tanaka A., Bozek G., Nicolae D. and Storb U. (2005) The very 5 end and the constant region of Ig genes are spared from somatic mutation because AID does not access these regions. J. Exp. Med. 202, 1443-1454.
90. Longerich S., Basu U., Alt F. and Storb U. (2006) AID in somatic hypermutation and class switch recombination. Curr. Opin. Immunol. 18, 164-174.
91. Wagner S.D. and Neuberger M.S. (1996) Somatic hypermutation of immunoglobulin genes.Annu. Rev. Immunol. 14, 441-457.
92. Michael N., Martin T.E., Nicolae D., Kim N., Padjen K., Zhan P., Nguyen H., Pinkert C. and Storb U. (2002) Effects of sequence and structure on the hypermutability of immunoglobulin genes. Immunity 16, 123-134.
93. Murre C. (2005) Helix-loop-helix proteins and lymphocyte development. Nat. Immunol. 6, 1079-1086.
94. Conlon T.M. and Meyer K.B. (2006) The chicken Ig light chain 3′-enhancer is essential for gene expression and regulates gene conversion via the transcription factor E2A. Eur. J. Immunol. 36, 139-148.
95. Goldfarb A.N., Flores J.P. and Lewandowska K. (1996) Involvement of the E2A basic helix-loop-helix protein in immunoglobulin heavy chain class switching. Mol. Immunol. 33, 947-956.
96. Michael N., Shen H.M., Longerich S., Kim N., Longacre A. and Storb U. (2003) The E box motif CAGGTG enhances somatic hypermutation without enhancing transcription. Immunity 19, 235-242.
97. Schoetz U., Cervelli M., Wang Y.D., Fiedler P. and Buerstedde J.M. (2006) E2A expression stimulates Ig hypermutation. J. Immunol. 177, 395-400.
98. Sayegh C.E., Quong M.W., Agata Y. and Murre C. (2003) E-proteins directly regulate expression of activation-induced deaminase in mature B cells. Nat. Immunol. 4, 586-593.
99. Li Z., Luo Z. and Scharff M.D. (2004) Differential regulation of histone acetylation and generation of mutations in switch regions is associated with Ig class switching. Proc. Natl. Acad. Sci. USA 101, 15428-15433.
100. Odegard V.H., Kim S.T., Anderson S.M., Shlomchik M.J. and Schatz D.G. (2005) Histone modifications associated with somatic hypermutation. Immunity 23, 101-110.
101. Wang L., Whang N., Wuerffel R. and Kenter A.L. (2006) AID-dependent histone acetylation is detected in immunoglobulin S regions. J. Exp. Med. 203, 215-226.
102. Woo C.J., Martin A. and Scharff M.D. (2003) Induction of somatic hypermutation is associated with modifications in immunoglobulin variable region chromatin. Immunity 19, 479-489.
103. Kuppers R. (2005) Mechanisms of B-cell lymphoma pathogenesis. Nat. Rev. Cancer 5, 251-262.
104. Johnston J.M. and Carroll W.L. (1992) c-myc hypermutation in Burkitt's lymphoma. Leuk. Lymphoma 8, 431-439.
105. Pasqualucci L., Neumeister P., Goossens T., Nanjangud G., Chaganti R.S., Kuppers R. and Dalla-Favera R. (2001) Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 412, 341-346.
106. Shen H.M., Peters A., Baron B., Zhu X. and Storb U. (1998) Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. Science 280, 1750-1752.
107. Duquette M.L., Pham P., Goodman M.F. and Maizels N. (2005) AID binds to transcription-induced structures in c-MYC that map to regions associated with translocation and hypermutation. Oncogene 24, 5791-5798.
108. Ramiro A.R., Jankovic M., Callen E., Difilippantonio S., Chen H.T., McBride K.M., Eisenreich T.R., Chen J., Dickins R.A., Lowe S.W., Nussenzweig A. and Nussenzweig M.C. (2006) Role of genomic instability and p53 in AID-induced c-myc-Igh translocations. Nature 440, 105-109.
109. Ramiro A.R., Jankovic M., Eisenreich T., Difilippantonio S., Chen-Kiang S., Muramatsu M., Honjo T., Nussenzweig A. and Nussenzweig M.C. (2004) AID is required for c-myc/IgH chromosome translocations in vivo. Cell 118, 431-438.